IO Biotech Inc [IOBT] stock prices are down -1.78% to $0.63 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IOBT shares have gain 8.07% over the last week, with a monthly amount drifted -9.86%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
IO Biotech Inc [NASDAQ: IOBT] stock has seen the most recent analyst activity on September 30, 2025, when TD Cowen downgraded its rating to a Hold. Previously, Morgan Stanley downgraded its rating to Equal-Weight on September 30, 2025, and kept the price target unchanged to $0.39.
The stock price of IO Biotech Inc [IOBT] has been fluctuating between $0.32 and $2.79 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. IO Biotech Inc [NASDAQ: IOBT] shares were valued at $0.63 at the most recent close of the market. An investor can expect a potential return of 376.19% based on the average IOBT price forecast.
Analyzing the IOBT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.21, Equity is -4.65 and Total Capital is -4.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6096 points at the first support level, and at 0.5912 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6643, and for the 2nd resistance point, it is at 0.7006.
Ratios To Look Out For
It’s worth pointing out that IO Biotech Inc [NASDAQ:IOBT]’s Current Ratio is 2.01. Further, the Quick Ratio stands at 2.01, while the Cash Ratio is 1.67.
Transactions by insiders
Recent insider trading involved Hunter Heidi, Director, that happened on May 30 ’25 when 15000.0 shares were purchased.
